US 11490643
Lactobacillus casei for treating obesity and associated metabolic disorders
granted A61KA61K35/747A61P
Quick answer
US patent 11490643 (Lactobacillus casei for treating obesity and associated metabolic disorders) held by PrecisionBiotics Group Limited expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PrecisionBiotics Group Limited
- Grant date
- Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/747, A61P, A61P1/14, A61P1/16